menu
    • menu

    Company profile for Forbius

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Forbius (Formation Biologics) is a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius was founded in 2011 as a management-led spin out from YM BioSciences, prior to YM's acquisition by Gilead. Forbius’ medicines are designed to radically transform patients’ lives. Our strength is utilizing our knowledge of biology and diverse prote...
    Forbius (Formation Biologics) is a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius was founded in 2011 as a management-led spin out from YM BioSciences, prior to YM's acquisition by Gilead. Forbius’ medicines are designed to radically transform patients’ lives. Our strength is utilizing our knowledge of biology and diverse protein engineering technologies to design superior inhibitors of validated biological pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ForbiusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Brazos Street, Suite 930 Austin, Texas 78701
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://forbius.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/forbius
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bristol Myers Squibb completes acquisition of Forbius
    Bristol Myers Squibb completes acquisition of Forbius

    22 Sep 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=131307&sid=2

    PHARMABIZ
    22 Sep 2020
    Share Share
    Bristol Myers Squibb Completes Acquisition of Forbius
    Bristol Myers Squibb Completes Acquisition of Forbius

    21 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200921005721/en

    BUSINESSWIRE
    21 Sep 2020
    Share Share
    BMS agrees to acquire biotherapeutics developer Forbius
    BMS agrees to acquire biotherapeutics developer Forbius

    25 Aug 2020

    // PHARMACEUTICALTECHNOLOGY

    https://www.pharmaceutical-technology.com/news/bms-acquires-forbius/

    PHARMACEUTICALTECHNOLOGY
    25 Aug 2020
    Share Share
    Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta
    Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta

    24 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/canadacom/20200824005159/en/Bristol-Myers-Squibb-Enters-Agreement-Acquire-Forbius

    BUSINESSWIRE
    24 Aug 2020
    Share Share
    Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta
    Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta

    24 Aug 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/bristol-myers-squibb-enters-agreement-to-acquire-forbius-adding-lead-tgf-beta-asset-to-portfolio/?s=79

    BIOSPACE
    24 Aug 2020
    Share Share
    Forbius Completes Phase 1 Oncology Dose-Escalation with AVID200
    Forbius Completes Phase 1 Oncology Dose-Escalation with AVID200

    08 Nov 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191108005112/en/Forbius-Completes-Phase-1-Oncology-Dose-Escalation-AVID200/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    BUSINESSWIRE
    08 Nov 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search